| scholarly article | Q13442814 |
| P50 | author | Wesley H Stepp | Q83393307 |
| Timothy K Eitas | Q88942224 | ||
| P2093 | author name string | Zhi Hong | |
| David van Duin | |||
| Bruce A Cairns | |||
| Samuel W Jones | |||
| Lucas Sjeklocha | |||
| James Callahan | |||
| Yolanda Sanchez | |||
| Robert Maile | |||
| Laquanda Knowlin | |||
| Shiara Ortiz-Pujols | |||
| Scott Berger | |||
| Peter Gough | |||
| Caitlin Riley | |||
| Clayton V Long | |||
| P2860 | cites work | Changes in circulating levels of an anti-inflammatory cytokine interleukin 10 in burned patients. | Q52078708 |
| Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome | Q60364278 | ||
| Appearance of monocyte chemoattractant protein 1 (MCP-1) early after thermal injury: role in the subsequent development of burn-associated type 2 T-cell responses | Q74492684 | ||
| Role of MCP-1 in endotoxemia and sepsis | Q81170442 | ||
| Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress | Q24555749 | ||
| New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress | Q24632281 | ||
| Burn wound healing and treatment: review and advancements | Q27013939 | ||
| CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages | Q27308841 | ||
| Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery | Q27704504 | ||
| Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE | Q28236539 | ||
| When NRF2 talks, who's listening? | Q28384223 | ||
| Nrf2 plays a pivotal role in protection against burn trauma-induced intestinal injury and death | Q28387028 | ||
| Nuclear factor E2-related factor-2 (Nrf2) is required for NLRP3 and AIM2 inflammasome activation | Q28387955 | ||
| Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial | Q28393862 | ||
| Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription | Q28395088 | ||
| Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression | Q29615589 | ||
| CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization | Q33553562 | ||
| Polymorphism of Nrf2, an antioxidative gene, is associated with blood pressure and cardiovascular mortality in hemodialysis patients | Q33712021 | ||
| Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: biochemical, pharmacological and toxicological implications | Q33970540 | ||
| Proteomic analysis shows synthetic oleanane triterpenoid binds to mTOR | Q33983503 | ||
| A phase I first-in-human trial of bardoxolone methyl in patients with advanced solid tumors and lymphomas | Q34277465 | ||
| Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer | Q34295041 | ||
| Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties | Q34415403 | ||
| Genetic polymorphism in the NRF2 gene as a prognosis marker for cancer chemotherapy | Q34448767 | ||
| Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis | Q34498927 | ||
| The effect of ex vivo CDDO-Me activation on nuclear factor erythroid 2-related factor 2 pathway in white blood cells from patients with septic shock | Q35067749 | ||
| Association between early airway damage-associated molecular patterns and subsequent bacterial infection in patients with inhalational and burn injury | Q35574722 | ||
| Differential expression of the Nrf2-linked genes in pediatric septic shock. | Q36070766 | ||
| Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease. | Q36293645 | ||
| Burn size determines the inflammatory and hypermetabolic response | Q36392636 | ||
| Optimizing healing of the acute wound by minimizing complications | Q37013570 | ||
| Survivors versus nonsurvivors postburn: differences in inflammatory and hypermetabolic trajectories | Q37067305 | ||
| Derivation and validation of Spo2/Fio2 ratio to impute for Pao2/Fio2 ratio in the respiratory component of the Sequential Organ Failure Assessment score | Q37180760 | ||
| The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation | Q37245219 | ||
| A global plan for burn prevention and care | Q37370836 | ||
| Monocyte chemoattractant protein-1 (MCP-1): an overview | Q37481208 | ||
| Biomarkers in cardiovascular medicine | Q37500635 | ||
| Toward clinical application of the Keap1-Nrf2 pathway | Q38105775 | ||
| Role of Nrf2 in protection against acute kidney injury | Q38115682 | ||
| RECENT ADVANCES IN BIOMARKERS IN SEVERE BURNS. | Q38697915 | ||
| Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studies | Q38982139 | ||
| Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury | Q40154556 | ||
| Cytokine polymorphisms associated with carotid intima-media thickness in stroke patients | Q40319930 | ||
| Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. | Q41067804 | ||
| Bardoxolone methyl (BARD) ameliorates aristolochic acid (AA)-induced acute kidney injury through Nrf2 pathway | Q42706839 | ||
| The absence of macrophage Nrf2 promotes early atherogenesis | Q43901244 | ||
| The nuclear factor erythroid 2-related factor 2 activator oltipraz attenuates chronic hypoxia-induced cardiopulmonary alterations in mice | Q46868217 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e0184164 | |
| P577 | publication date | 2017-09-08 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Differential regulation of innate immune cytokine production through pharmacological activation of Nuclear Factor-Erythroid-2-Related Factor 2 (NRF2) in burn patient immune cells and monocytes | |
| P478 | volume | 12 |
| Q47105575 | Correction: Differential regulation of innate immune cytokine production through pharmacological activation of Nuclear Factor-Erythroid-2-Related Factor 2 (NRF2) in burn patient immune cells and monocytes |
| Q92124873 | One-hit wonder: Late after burn injury, granulocytes can clear one bacterial infection but cannot control a subsequent infection |
| Q90070325 | Sex-Based Differences in Inpatient Burn Mortality |
| Q64116359 | The role of nuclear factor erythroid-2-related factor 2 expression in radiocontrast-induced nephropathy |
Search more.